PRICE HISTORY.
Use the left and right arrow keys to inspect dated observations. Home selects the first observation and End selects the latest.
Key numbers
Published fundamentals and the date each figure was recorded.
Martin and Harris Laboratories Ltd is a pharmaceutical company established in 1993. The company describes itself as engaged in research and manufacturing of finished dosage forms. It offers diversified products and drug-development and manufacturing solutions with value-added services. Its manufacturing units serve domestic and international markets and have experience making complex dosage forms and specialty formulations. The Roorkee facility, which began production in 2008, has manufacturing equipment operating with quality-control techniques under international guidelines. It makes tablets, capsules, dry syrup, liquid orals, ointments and drug powder and has a separate hormonal-products section; it also has newer finished-dosage-form technologies, including dispersible and modified-release tablets. The Gagret unit began production in 2010 and supports business continuity and capacity expansion. The company also says it collaborates with finished-dosage-form, API and contract-manufacturing organizations to commercialize technology in certain specialized products.
About this company
Martin and Harris Laboratories Limited is an India-based pharmaceutical company incorporated in 1993 and headquartered in Gurgaon, Haryana. It is associated with the Apeejay Stya & Svran group and operates in the manufacturing of pharmaceuticals, medicinal chemicals and botanical products, with manufacturing units in Himachal Pradesh and Uttarakhand. Alongside its core pharmaceutical formulations business, the company maintains a treasury and investment portfolio that contributes a notable share of its income. It is a long-established manufacturer that has not listed on a public stock exchange. As an unlisted company, its equity shares are not traded on the NSE or BSE and change hands privately. Investors should note that unlisted and pre-IPO shares carry higher risk and lower liquidity than listed securities, may be difficult to value or exit, and prices can vary widely between counterparties. This information is provided for general reference only and is not investment advice.
COMPANY REGISTRY · ON FILE
THE CREW · BOARD & MANAGEMENT
COMMON QUESTIONS.
Is Martin and Harris Laboratories Limited listed on the stock exchange?+
No. As of 2 September 2026, Martin and Harris Laboratories Limited is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
What is the Martin and Harris Laboratories Limited unlisted share price?+
As of 2 September 2026, the indicative unlisted share price of Martin and Harris Laboratories Limited is ₹895 per share. This is an over-the-counter reference price, not a stock-exchange quote.
What indicative minimum amount is displayed for Martin and Harris Laboratories Limited unlisted shares?+
The displayed unit count is 15 share(s); at the indicative price of about ₹895, the displayed amount is approximately ₹13,425. This is a display convention, not evidence of inventory, an order minimum or a quote.
What is the ISIN of Martin and Harris Laboratories Limited?+
The recorded ISIN of Martin and Harris Laboratories Limited is INE03VV01015. An ISIN is a 12-character security identifier. Verify it against the issuer and the relevant depository record before using it for any transfer or documentation.
Is trading in Martin and Harris Laboratories Limited unlisted shares legal in India?+
Unlisted shares can be transferred off-market in India, but the legal, tax and compliance position depends on the security, parties, documents and current rules. Verify the intermediary, issuer restrictions and applicable requirements before proceeding.
Is there a lock-in period for unlisted shares?+
A post-listing lock-in may apply under the rules in force at the time. The period and any exemptions can depend on the holder and acquisition, so check the current regulation and the issuer's offer documents rather than relying on a generic period.
Do you guarantee returns?+
No. Unlisted shares carry higher risk and lower liquidity than listed shares. Returns depend on company performance, market conditions and future listing outcomes. This is information only, not investment advice.